Novartis Pharma GmbH

Pharmaceutical Companies · Nürnberg

Novartis Pharma GmbH is the German subsidiary of Schweizer Pharmariesen Novartis AG, based in Nürnberg.

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Novartis Pharma GmbH – Address & Contact

Address

Roonstr. 25
90429 Nürnberg

Novartis Pharma GmbH Overview

Novartis Pharma GmbH is a pharmaceutical company based in Nürnberg, Bayern. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Activities & Products

Pharmaceutical companies such as Novartis Pharma GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).

About Novartis Pharma GmbH

Wir denken Medizin gemasam neu, um the Leben the Menschen zu verbessern and zu verlängern.

Location & Contact

Novartis Pharma GmbH can be reached at the following address: Roonstr. 25, 90429 Nürnberg – Phone: 09112730. For current information and enquiries, please contact the company directly.

More information: Pharmaunternehmen in Bayern or all Pharmaunternehmen in Germany on Sanoliste.

Frequently asked questions about Novartis Pharma GmbH

What does Novartis Pharma GmbH do?

Novartis Pharma GmbH stellt verschreibungspflichtige Medikamente and Generika her. Schwerpunkt liegt thezeit on chronischer Herzinsuffizienz and Fettstoffwechselstörungen. Weitere Anwendungsgebiete are Ophthalmologie, Atemwege, Neurologie, Onkologie and Zell- and Gentherapie.

Novartis Pharma GmbH on social media

Pharmaceutical Companies in Bayern

All Pharmaceutical Companies in Bayern on Sanoliste — or discover all categories by federal state.

Last updated: 17.03.2026 · Category: Pharmaceutical Companies